How to keep your integrity when performing sponsored (Imaging) trials

Paul M. Parizel, Wim Van Hecke

Research output: Contribution to journalReview articlepeer-review

1 Citation (Scopus)


The broadening of imaging capabilities and the increasing capacity of imaging to quantitate biologic processes has increased industry interest in using imaging methods in new drug development. Investigators participating in industry-sponsored trials should be aware of how such trials differ from investigator-initiated, grant-funded research. In particular, investigators should be cognizant of possible ethical conflicts in the care of patients, the development and analysis of data, and issues related to the dissemination of results.

Original languageEnglish
Pages (from-to)842-847
Number of pages6
JournalJournal of the American College of Radiology
Issue number12
Publication statusPublished - 1 Jan 2011
Externally publishedYes


Dive into the research topics of 'How to keep your integrity when performing sponsored (Imaging) trials'. Together they form a unique fingerprint.

Cite this